Dr George Morstyn

Dr Morstyn is a medical graduate of Monash University, and obtained a PhD at the Walter and Eliza Hall Institute and a FRACP in medical oncology following a fellowship at the National Cancer Institute in the US. Dr George Morstyn has more than 25 years’ experience in the biotechnology industry including as Senior Vice President of Development and Chief Medical Officer at Amgen.

Dr Morstyn had overall responsibility globally for drug development in all therapeutic areas including neuroscience at Amgen, and was a member of the Operating Committee. Prior to joining Amgen, Dr Morstyn was the principal investigator on the earliest clinical studies of the haemopoietic colony stimulating factors (CSFs). The CSFs were subsequently approved and launched, and were a major medical breakthrough that have been used to reduce side effects of chemotherapy and enable transplantation in more than 20 million patients worldwide.

Since returning to Australia, Dr Morstyn has been a non-executive director of various for-profit and not for profit companies and biotechs. He is currently a Director of Actinogen Medical and Limos Therapeutics.